Abstract
Manipulation of the genetic machinery of cells both in vitro and in vivo is becoming an ever more important means of elucidating pathways of molecular and cellular biochemistry. In addition, gene therapy has been proposed as a novel and potentially powerful treatment for both inherited and acquired diseases. Successful gene transfer and gene blockade generally depend on high efficiency delivery of exogenous DNA or RNA into living cells, and much effort has therefore been focused on the development of methods for achieving this delivery in a safe and effective manner. We describe here our application of fusigenic Sendai virus (HVJ)-liposome technology toward the effective delivery of DNA into vascular smooth muscle cells (VSMC) in cell culture. Cellular uptake and intracellular distribution of oligodeoxynucleotide (ODN) after transfection with HVJ-liposome complexes was characterized using fluorescent (FITC)-labeled ODN, and the biologic effect of HVJ-liposome mediated transfection was demonstrated via inhibition of DNA synthesis in cultured VSMC using antisense ODN against basic fibroblast growth factor.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Beltinger C, Saragovi HU, Smith RM, LeSauteur L, Shah N, DeDionisio L, Christensen L, Raible A, Jarett L, Gewirtz AM: Binding, uptake, and intracellular trafficking of phosphorothioate-modified oligodeoxynucleotides. J Clin Invest 95: 1814–1823, 1995
Jaaskelainen I, Monkkonen J, Urtti A: Oligonucleotide-cationic liposome interactions. A physiochemical study. Biochim Biophys Acta 1195: 115–123, 1994
Nabel EG, Plautz G, Nabel GJ: Site-specific gene expression in vivoby direct gene transfer into the arterial wall. Science 249: 1285–1288, 1990
Chang MW, Barr E, Seltzer J, Jiang YQ, Nabel GJ, Nabel EG, Parmacek MS, Leiden JM: Cytostatic gene therapy for vascular proliferative disorders with a constitutively active form of the retinoblastoma gene product. Science 267: 518–522, 1995
Steg PG, Feldman LJ, Scoazec JY, Tahlil O, Barry JJ, Boulechfar S, Ragot T, Isner JM, Perricaudet M: Arterial gene transfer to rabbit endothelial and smooth muscle cells using percutaneous delivery of an adenoviral vector. Circ 90: 1648–1656, 1994
Quantin B, Perricaudet LD, Tajbakhsh S, Mandel JL: Adenovirus as an expression vector in muscle cells in vivo. Proc Natl Acad Sci USA 89: 2581–2584, 1992
Fraley RT, Fornari CS, Kaplan S: Entrapment of a bacterial plasmid in phospholipid vesicles: potential for gene transfer. Proc Natl Acad Sci USA 76: 3348–3352, 1979
Felgner PL, Gader TR, Holm M, Roman R, Chan HW, Wenz M, Northrop JP, Ringold GM, Danielson M: Lipofectin: A highly efficient, lipid mediated DNA-transfection procedure. Proc Natl Acad Sci USA 84: 7413–7417, 1987
Zhu N, Liggitt D, Liu Y, Debs R: Systemic gene expression after intravenous DNA delivery into adult mice. Science 261: 209–211, 1993
Okada Y, Tadokoro J: Analysis of giant polynuclear cell formation caused by HVJ virus from Ehrlich's ascites tumor cells. Exp Cell Res 26: 108–118, 1961
Kaneda Y, Uchida T, Kim J, Ishiura M, Okada Y: The improved efficient method for introducing macromolecules into cells using HVJ (Sendai virus) liposomes with gangliosides. Exp Cell Res 173: 56–69, 1987
Okada Y: Sendai virus-induced cell fusion. Methods Enzymol 221: 18–41, 1993
Kaneda Y, Iwai K, Uchida T: Increased expression of DNA cointroduced with nuclear protein in adult rat liver. Science 243: 375–378, 1989
Okada Y, Koseki I, Kim J, Hashimotot T, Kanno Y, Matsui Y: Modification of cell membranes with viral envelopes during fusion of cells with HVJ (Sendai virus). Exp Cell Res 93: 368–378, 1975
Morishita R, Gibbons GH, Kaneda Y, Ogihara T, Dzau VJ: Novel and effective gene transfer technique for study of vascular renin angiotensin system. J Clin Invest 91: 2580–2585, 1993
Isaka Y, Fujiwara Y, Ueda N, Kaneda Y, Kamada T, Imai E: Glomerulosclerosis induced by in vivotransfection of transforming growth factor-? ?or platelet-derived growth factor gene into the rat kidney. J Clin Invest 92: 2597–2601, 1993
von der Leyen HE, Gibbons GH, Morishita R, Lewis NP, Zhang L, Nakajima M, Kaneda, Cooke JP, Dzau VJ: Gene therapy inhibiting neointimal vascular lesion: In vivogene transfer of endothelial-cell nitric oxide synthase gene. Proc Natl Acad Sci USA 92: 1137–1141, 1995
Mann MJ, Gibbons GH, Kernoff RS, Diet FP, Tsao P, Cooke JP, Kaneda Y, Dzau VJ: Genetic engineering of vein grafts resistant to atherosclerosis. Proc Natl Acad Sci USA 92: 4502–6, 1995
Salk J: A simplified procedure for titrating hemagglutinating capacity of influenza-virus and the corresponding antibody. J Immunol 69: 87–98, 1944
Goodwin GH, Nicholas RH, Johns EW: An improved large scale fractionation of high mobility group non-histone chromatin proteins. Biochim Biophys Acta 405: 280–91, 1975
Itoh H, Mukoyama M, Pratt RE, Dzau VJ: Specific blockade of basic fibroblast growth factor gene expression in endothelial cells by antisense oligonucleotides. Biochem Biophys Res Comm 188: 1205–13, 1992
Itoh H, Mukoyama M, Pratt RE, Dzau VJ: Multiple autocrine growth factors modulate vascular smooth muscle cells growth response to angiotensin II. J Clin Invest 91: 2268–74, 1993
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Mann, M.J., Morishita, R., Gibbons, G.H. et al. DNA transfer into vascular smooth muscle using fusigenic Sendai virus (HJV)-liposomes. Mol Cell Biochem 172, 3–12 (1997). https://doi.org/10.1023/A:1006801807206
Issue Date:
DOI: https://doi.org/10.1023/A:1006801807206